The MarketWatch News Department was not involved in the creation of this content. Sales of patented medicines in Canada were $22.1 billion in 2024, a 10.9% increase over the year before OTTAWA, ON, ...
As we previously reported, on December 19, 2024, the Patented Medicine Prices Review Board (PMPRB) released its Draft Guidelines for PMPRB Staff regarding Administrative Process for Excessive Price ...
The Patented Medicine Prices Review Board (PMPRB), Canada’s federal gatekeeper under the Patent Act, sets maximum prices for ...
On March 6, 2025, the Patented Medicine Prices Review Board (PMPRB) announced that Thomas Digby stepped down from his role as Chairperson of the PMPRB. Vice-Chairperson Anie Perrault is now serving as ...
But that doesn’t mean the drug pricing tribunal can’t look at past years’ data to inform future reviews of drug prices, says director general Guillaume Couillard.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback